Senior Process Engineer
LOTTE BIOLOGICS
Senior Process Engineer
LOTTE BIOLOGICS
GMP CDMO for biologics and ADCs
We are LOTTE BIOLOGICS! Delivering Therapies That Enable a Healthier World.
A new company, built on 80 years of tradition. We embody our core values of being Inspired by Science, Embracing Diversity, Fostering Talent, and Connecting Lives. Our mission is to be the most trusted partner in the industry, with high standards of quality and continuous innovation, to reliably deliver benefits for patients worldwide.
Position Summary
The Senior Process Engineer is a key technical leader responsible for supporting the successful transfer, fit assessment, and lifecycle optimization of monoclonal antibody (mAb) and antibody-drug conjugate (ADC) processes within a CDMO manufacturing environment. This role partners closely with MS&T, Plant/Facilities Engineering, and Capital Project Engineering to ensure manufacturing readiness, effective facility fit, and robust process performance.
The position requires deep expertise in bioprocessing operations and a strong understanding of equipment design, facility capabilities, and capital project execution to enable seamless delivery of client programs from tech transfer through commercial manufacturing.
This role directly enables:
Duties & Responsibilities
Education & Experience
Knowledge, Skills, Abilities
Physical Demands
Work Environment
Travel
This role may require up to 10% travel.
Target Bonus
16%
Work Location:
East Syracuse, NY
We are an Equal Employment Opportunity (“EEO”) Employer.
We believe that women, people of color, veterans and LGBTQ communities must participate in the work we do, so we strongly encourage applications from people with these identities or who are members of underrepresented communities! If this is the work that you want to do, in a culture of inclusion and excellence with the goal of making our world to be a healthier place, then please apply today!
New York Pay Range 91000 - 142000 USD
GMP CDMO for biologics and ADCs
LOTTE BIOLOGICS provides GMP manufacturing services for biopharmaceuticals, operating a Syracuse, NY campus with a total bioreactor capacity of 40,000 L (eight 5,000 L stainless steel bioreactors) and extensive QC labs and warehousing, supported by regulatory approvals worldwide. The company is expanding into Antibody-Drug Conjugates (ADC) with on-site drug substance production and conjugation, backed by over $100 million invested in ADC modalities, offering an end-to-end service from drug substance manufacturing to ADC conjugation. Looking ahead, it is constructing three advanced bio plants in Songdo, South Korea, each with eight 15,000 L bioreactors plus additional 3,000 L units to support clinical production, aiming for a combined bioreactor capacity exceeding 360,000 L. The overall goal is to become a top-tier global CDMO in the biopharmaceutical industry, delivering therapies to patients worldwide.
Explore more opportunities at LOTTE BIOLOGICS